FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gerd Lümmen

Research Profile

Disorders

Concepts & Ideas

Physiology

Cell Movement

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Stefan Hauser; Monika Kogej; Gerd Lümmen; Stefan C Müller; Jochen VON Pezold; Roland Vorreuther; Guido Fechner; Jörg Ellinger
Serum DNA hypermethylation in patients with bladder cancer: results of a prospective multicenter study.
Stefan Hauser; Monika Kogej; Gerd Lümmen; Stefan C Müller; Jochen Von Pezold; Alexander von Ruecker; Roland Vorreuther; Patrick J Bastian; Guido Fechner; Jörg Ellinger
Cell-free serum DNA in patients with bladder cancer: results of a prospective multicenter study.
Frank vom Dorp; S Tschirdewahn; Gerd Lümmen
[Intravesical therapy of non-muscle invasive bladder tumors].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gerd Lümmen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Stefan Hauser; Monika Kogej; Gerd Lümmen; Stefan C Müller; Jochen VON Pezold; Roland Vorreuther; Guido Fechner; Jörg Ellinger
Serum DNA hypermethylation in patients with bladder cancer: results of a prospective multicenter study.
Anticancer research 2013;33(3):779-84.
2012: Stefan Hauser; Monika Kogej; Gerd Lümmen; Stefan C Müller; Jochen Von Pezold; Alexander von Ruecker; Roland Vorreuther; Patrick J Bastian; Guido Fechner; Jörg Ellinger
Cell-free serum DNA in patients with bladder cancer: results of a prospective multicenter study.
Anticancer research 2012;32(8):3119-24.
2012: Frank vom Dorp; S Tschirdewahn; Gerd Lümmen
[Intravesical therapy of non-muscle invasive bladder tumors].
Der Urologe. Ausg. A 2012;51(2):257-64.
2011: Frank vom Dorp; Harald Sanders; Christof Boergermann; Gerd Lümmen; Herbert Rübben; Karl H Jakobs; Martina Schmidt
Inhibition of Rho-kinase abrogates migration of human transitional cell carcinoma cells: results of an in vitro study.
Urologia internationalis 2011;86(2):220-7.
2008: P J Bastian; M Lörken; H Euler; Gerd Lümmen; H P Bastian
[Results of the evaluation of 85,337 urinary stone analyses].
Aktuelle Urologie 2008;39(4):298-304.
2007: Herbert Sperling; Susanne Krege; Gerd Lümmen; Herbert Rübben
[Testicular perfusion injury. Cytokines and cell adhesion molecules in humans].
Der Urologe. Ausg. A 2007;46(9):1033-40.
2007: Gerd Lümmen; Herbert Rübben; T Schneider; Herbert Sperling
[Prevention of osteoporosis--important for the urologist?].
Der Urologe. Ausg. A 2007;46(6):651-5.
2007: Marcus Schenck; Christof Börgermann; Tobias Jäger; Frank vom Dorp; Herbert Sperling; Herbert Rübben; Gerd Lümmen
[Immunotherapy of metastatic renal cell carcinoma with interleukin-2, interferon-alpha2a and erythropoietin-beta].
Der Urologe. Ausg. A 2007;46(5):528-34.
2007: Tobias Jäger; Andreas Eisenhardt; Herbert Rübben; Gerd Lümmen
[Does cigarette smoking influence the survival of patients with prostate cancer?].
Der Urologe. Ausg. A 2007;46(4):397-400.
2006: A Rose; Herbert Sperling; J Steffens; Gerd Lümmen; B Hauffa; D Rohrmann; S Conrad; P Hoyer; Herbert Rübben
[Multimodal therapy of cryptorchism].
Der Urologe. Ausg. A 2006;45 Suppl 4():214-8.
2006: Gerd Lümmen; Tobias Jäger; F Sommer; T Ebert; B Schmitz-Draeger
[Nutrition, lifestyle, physical activity, and supportive care during chemotherapeutic treatment].
Der Urologe. Ausg. A 2006;45(5):555-8, 560-5.
2006: Ulrich H Frey; Gerd Lümmen; Tobias Jäger; Karl-Heinz Jöckel; Kurt W Schmid; Herbert Rübben; Norbert Müller; Winfried Siffert; Andreas Eisenhardt
The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 1):759-63.
2005: Andreas Eisenhardt; Winfried Siffert; Dieter Rosskopf; Michael Musch; Max Mosters; Ulla Roggenbuck; Karl-Heinz Jöckel; Herbert Rübben; Gerd Lümmen
Association study of the G-protein beta3 subunit C825T polymorphism with disease progression in patients with bladder cancer.
World journal of urology 2005;23(4):279-86.
2005: Herbert Sperling; Gerd Lümmen; Susanne Krege; Herbert Rübben
[Use of free dermal grafts in urology].
Der Urologe. Ausg. A 2005;44(7):751-5.
2005: Marcus Schenck; Gerd Lümmen; M Stuschke; Kurt W Schmid; Herbert Rübben
[Principle problems of lymph node surgery].
Der Urologe. Ausg. A 2005;44(6):605-7.
2005: Herbert Sperling; Gerd Lümmen; Herbert Rübben
[Use of lubricants in urology. Indications and results].
Der Urologe. Ausg. A 2005;44(6):662-6.
2005: Ulrich H Frey; Andreas Eisenhardt; Gerd Lümmen; Herbert Rübben; Karl-Heinz Jöckel; Kurt W Schmid; Winfried Siffert
The T393C polymorphism of the G alpha s gene (GNAS1) is a novel prognostic marker in bladder cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(4):871-7.
2005: Andreas Eisenhardt; Ulrich H Frey; Monika Tack; Dieter Rosskopf; Gerd Lümmen; Herbert Rübben; Winfried Siffert
Expression analysis and potential functional role of the CXCR4 chemokine receptor in bladder cancer.
European urology 2005;47(1):111-7.
2004: Herbert Sperling; R Rossi; Gerd Lümmen; Herbert Rübben
[Testosterone and the prostate].
Der Urologe. Ausg. A 2004;43(9):1092-6.
2004: Susanne Krege; C Friedrich; Gerd Lümmen; Ludger Pientka; H Rübben
[Geriatric assessment. Is it significantly helpful in selection of elderly tumour patients for a difficult therapy?].
Der Urologe. Ausg. A 2004;43(8):922-9.
2004: Gerd Lümmen; Marcus Schenck; Christof Börgermann; Andreas Eisenhardt; Frank vom Dorp; Herbert Sperling; Herbert Rübben
[Inhaled immunotherapy for pulmonary metastases of renal cell cancer].
Der Urologe. Ausg. A 2004;43(4):457-61.
2003: Gerd Lümmen; Herbert Rübben
[Chemotherapy in the elderly].
Der Urologe. Ausg. A 2003;42(11):1436-44.
2003: Herbert Sperling; Gerd Lümmen; Tim Schneider; Herbert Rübben
[New treatment options for erectile dysfunction. Pharmacologic and nonpharmacologic options].
Herz 2003;28(4):314-24.
2003: Gerd Lümmen; Herbert Rübben
G-protein-coupled receptors, cell motility and proliferation.
Urologia internationalis 2003;71(1):1-7.
2002: Gerd Lümmen; Herbert Sperling; T Schneider; Thomas Otto; Herbert Rübben
[Urothelial carcinoma. Role of G-protein coupled receptors in cell movement and proliferation].
Der Urologe. Ausg. A 2002;41(4):353-61.
2002: Herbert Rübben; Gerd Lümmen
[Tumors in the elderly].
Der Urologe. Ausg. A 2002;41(4):333-7.
2002: Gerd Lümmen; Herbert Sperling; Andreas Eisenhardt; Frank vom Dorp; Thomas Otto; Herbert Rübben
Influence of pertussis toxin on superficial bladder carcinoma in rats.
Urological research 2002;30(3):199-203.
2002: Axel Bex; Thomas Otto; Gerd Lümmen; Herbert Rübben
Phase II study of repeated single 24-hour infusion of low-dose 5-fluorouracil for palliation in symptomatic hormone-refractory prostate cancer.
Urologia internationalis 2002;69(4):273-7.
2001: Susanne Krege; Axel Bex; Gerd Lümmen; Herbert Rübben
Male-to-female transsexualism: a technique, results and long-term follow-up in 66 patients.
BJU international 2001;88(4):396-402.
2001: T Schneider; Herbert Sperling; Gerd Lümmen; J Syllwasschy; Herbert Rübben
Does penile size in younger men cause problems in condom use? a prospective measurement of penile dimensions in 111 young and 32 older men.
Urology 2001;57(2):314-8.
2001: T Schneider; Herbert Sperling; Gerd Lümmen; H Rübben
[Sachse internal urethrotomy. Is erectile dysfuction a possible complication?].
Der Urologe. Ausg. A 2001;40(1):38-41.
2000: Herbert Sperling; Gerd Lümmen; C Schmidt; Herbert Rübben
Cryptorchidism: fowler-stephens procedure or autotransplantation-a new experimental model.
Urology 2000;56(5):886-90.
2000: Herbert Sperling; G Becker; U Heemann; Gerd Lümmen; T Philipp; H Rübben
The Whitaker test, a useful tool in renal grafts?
Urology 2000;56(1):49-52.
2000: Franz Recker; Maciej Kwiatkowski; T Piironen; K Pettersson; A Huber; Gerd Lümmen; R Tscholl
Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen.
Urology 2000;55(4):481-5.
2000: Franz Recker; Gerd Lümmen
[Prostatic carcinoma. Screening--when and what?].
Therapeutische Umschau. Revue thérapeutique 2000;57(1):33-7.
2000: Ulrich Rümenapp; Gerd Lümmen; Sebastian Virchow; J Hanske; Dagmar Meyer Zu Heringdorf; Karl H Jakobs
Sphingolipid receptor signaling and function in human bladder carcinoma cells: inhibition of LPA- but enhancement of thrombin-stimulated cell motility.
Naunyn-Schmiedeberg's archives of pharmacology 2000;361(1):1-11.
1999: Thomas Otto; Axel Bex; Gerd Lümmen; Herbert Rübben
Influence of interferon-alpha2b (IFN-alpha2b) on the prevention of locally advanced bladder carcinoma in mice.
Urological research 1999;27(6):489-92.
1999: Herbert Sperling; Gerd Lümmen; T Otto; C Ender-Sperling; H Rübben
The need for further reproductive medical advice after vasectomy reversal.
World journal of urology 1999;17(5):301-4.
1999: Thomas Otto; Gerd Lümmen; T Kälble; Franz Recker; Susanne Krege; Axel Bex; F Noll; Herbert Rübben
Intravesical therapy with pertussis toxin before radical cystectomy in patients with bladder cancer: a Phase I study.
Urology 1999;54(3):458-60.
1999: Thomas Otto; Gerd Lümmen; A Be; Herbert Rübben; Avraham Raz
Tumor cell motility. A novel therapeutic target in bladder carcinoma, experimental and clinical results.
Advances in experimental medicine and biology 1999;462():469-76.
1999: Herbert Sperling; Gerd Lümmen; HJ Luboldt; Herbert Rübben
[Secondary erectile dysfunction. Is oral medication in the diagnostic phase indicated?].
Der Urologe. Ausg. A 1999;38(1):56-9.
1998: Franz Recker; Maciej Kwiatkowski; T Piironen; K Pettersson; Gerd Lümmen; M Wernli; J Wiefelspütz; S F Graber; Mark Goepel; A Huber; R Tscholl
The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
Cancer 1998;83(12):2540-7.
1998: Gerd Lümmen; Herbert Sperling; Axel Bex; Thomas Otto; Herbert Rübben
Modern concepts in the therapy of urinary tract (kidney, ureter, bladder and prostate) tumours.
Pharmacological research : the official journal of the Italian Pharmacological Society 1998;38(3):151-64.
1998: Gerd Lümmen; Herbert Sperling; HJ Luboldt; Thomas Otto; Herbert Rübben
Granulocyte-macrophage colony-stimulating factor and interferon-alpha 2B in patients with advanced renal cell carcinoma.
Urologia internationalis 1998;61(4):215-9.
1998: Gerd Lümmen; Herbert Sperling; HJ Luboldt; Thomas Otto; Herbert Rübben
Phase II trial of titanocene dichloride in advanced renal-cell carcinoma.
Cancer chemotherapy and pharmacology 1998;42(5):415-7.
1998: Franz Recker; Maciej Kwiatkowski; K Pettersson; T Piironen; Gerd Lümmen; A Huber; R Tscholl
Enhanced expression of prostate-specific antigen in the transition zone of the prostate. A characterization following prostatectomy for benign hyperplasia.
European urology 1998;33(6):549-55.
1997: Gerd Lümmen; Sebastian Virchow; Ulrich Rümenapp; Martina Schmidt; Thomas Wieland; Thomas Otto; Herbert Rübben; Karl H Jakobs
Identification of G protein-coupled receptors potently stimulating migration of human transitional-cell carcinoma cells.
Naunyn-Schmiedeberg's archives of pharmacology 1997;356(6):769-76.
1997: Gerd Lümmen; Herbert Sperling; Herbert Rübben
[Burkitt lymphoma as a rare cause of hydronephrosis].
Der Urologe. Ausg. A 1997;36(3):239-42.
1997: Herbert Sperling; Mark Goepel; Gerd Lümmen; F Stöblen; H Rübben
[Post-traumatic priapism in a 10-year-old boy].
Der Urologe. Ausg. A 1997;36(2):162-4.
1997: Gerd Lümmen; Herbert Sperling; M Pietsch; Thomas Otto; Herbert Rübben
[Treatment and follow-up of patients with squamous epithelial carcinoma of the penis].
Der Urologe. Ausg. A 1997;36(2):157-61.
1996: Gerd Lümmen; Mark Goepel; S Möllhoff; A Hinke; Thomas Otto; Herbert Rübben
Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma.
The Journal of urology 1996;155(2):455-8.
1995: Herbert Sperling; B Batke; Gerd Lümmen; D Propping; T Katzorke; F B Kolodziej; Herbert Rübben
[MESA (microsurgical epididymal sperm aspiration) and IVF (in vitro fertilization). A therapy concept in treatment of male infertility].
Der Urologe. Ausg. A 1995;34(5):409-12.